Fingerprint
Dive into the research topics of 'Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder
Sharon Ratner, Nathaniel Laor, Yifat Bronstein, Abraham Weizman, Paz Toren*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
42
Scopus
citations